Position in LH
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,904,280
+$362,386 QoQ
Shares Held
6,801
+17.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#377
of 1,040 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Summit Trail Advisors, LLC holds $40,569,660 across 16 Diagnostics & Research names. LH ranks #10 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
13,026 | $6,530,715 | |
| 2 | ILMN |
Illumina, Inc.
|
22,808 | $4,010,330 | |
| 3 | DHR |
Danaher Corp /De/
|
19,635 | $3,740,074 | |
| 4 | DGX |
Quest Diagnostics Inc
|
15,051 | $3,190,059 | |
| 5 | A |
Agilent Technologies, Inc.
|
23,182 | $3,079,265 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
13,010 | $2,950,537 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
14,384 | $2,779,276 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
4,777 | $2,514,803 |
All Filings in LH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,904,280 | 6,801 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,541,894 | 5,779 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,249,131 | 4,979 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $918,879 | 3,201 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $414,765 | 1,580 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $273,316 | 1,223 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $255,201 | 1,254 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||